Related Experiment Videos
Microtubule-interfering activity of parthenolide
Antonella Miglietta1, Francesca Bozzo, Ludovica Gabriel
1Department of Experimental Medicine and Oncology, University of Torino, Corso Raffaello 30, 10125 Torino, Italy. antonella.miglietta@unito.it
Chemico-Biological Interactions
|October 27, 2004
Summary
Parthenolide, a compound from medicinal herbs, shows anticancer potential by affecting microtubules. It enhances paclitaxel
Area of Science:
- Pharmacology
- Oncology
- Cell Biology
Background:
- Parthenolide, a sesquiterpene lactone from medicinal herbs, is recognized for its anti-inflammatory properties.
- Emerging research suggests parthenolide as a potential chemotherapeutic agent, but its precise mechanisms of action require further investigation.
- Understanding parthenolide's pharmacological pathways is crucial for developing novel anticancer strategies.
Purpose of the Study:
- To investigate the potential tubulin/microtubule-interfering activity of parthenolide as a basis for its anticancer properties.
- To compare the bioactivities of parthenolide alone and in combination with paclitaxel in human breast cancer MCF-7 cells.
- To explore the tubulin/microtubule system as a potential molecular target for parthenolide in combinational anticancer therapies.
Main Methods:
- In vitro tubulin assembly assays were performed to assess parthenolide's effect on microtubule polymerization.
- Light microscopy was utilized to observe parthenolide-induced alterations in microtubule networks and nuclear morphology in MCF-7 cells.
- Cell proliferation assays were conducted to evaluate the combined effects of parthenolide and paclitaxel on breast cancer cell growth.
Main Results:
- Parthenolide demonstrated in vitro stimulatory activity on tubulin assembly, promoting the formation of organized microtubule polymers.
- Parthenolide-induced changes in microtubule networks and nuclear morphology were observed only when combined with paclitaxel.
- Parthenolide significantly inhibited MCF-7 cell growth and enhanced the effectiveness of paclitaxel in combined treatments.
Conclusions:
- Parthenolide exhibits antimicrotubular and antiproliferative effects, potentially influencing the activity of microtubule-stabilizing agents like paclitaxel.
- The tubulin/microtubule system emerges as a novel molecular target for parthenolide.
- Parthenolide holds promise for developing new combinational anticancer strategies targeting the microtubule system.